Iterum Therapeutics Plc Inc. (ITRM) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 40.48%. However, over the last six months, the performance has been weaker by 7.26%. The price of ITRM increased 76.12% over the last 30 days. And in the last five days, it has surged by 51.73%.

Iterum Therapeutics Plc (ITRM) stock is currently valued at $1.18. During the last session, the stock experienced a remarkable rise, reaching $1.25 after opening at $0.95. The stock briefly dropped to $0.92 before ultimately closing at $0.88.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Iterum Therapeutics Plc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $1.54 on 02/06/23, while the lowest price for the same period was registered at $0.60 on 12/27/22.

52-week price history of ITRM Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Iterum Therapeutics Plc’s current trading price is -23.38% away from its 52-week high, while its distance from the 52-week low is 96.31%. The stock’s price range during this period has varied between$0.60 and $1.54. The Iterum Therapeutics Plc’s shares, which operate in the Healthcare, saw a trading volume of around 0.67 million for the day, a figure considerably higher than their average daily volume of 33360.0 over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Iterum Therapeutics Plc (ITRM) has experienced a quarterly rise of 22.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.39M and boasts a workforce of 14 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8813, with a change in price of +0.1100. Similarly, Iterum Therapeutics Plc recorded 47,585 in trading volume during the last 100 days, posting a change of +10.28%.

ITRM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ITRM stands at 5.89. Similarly, the long-term debt-to-equity ratio is also 5.80.

ITRM Stock Stochastic Average

As of today, Iterum Therapeutics Plc’s raw stochastic average for the last 50 days stands at 88.85%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 88.85%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 86.51% and 86.66%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts